Patents for C12R 1 - Micro-organisms (92,025)
10/2002
10/03/2002WO2002077258A1 Stereoselective reduction of substituted acetophenone
10/03/2002WO2002077253A1 Process for producing acrylamide using microbial catalyst having been washed with aqueous acrylic acid solution
10/03/2002WO2002077251A1 Method of recovering pinitol or chiro-inositol in high yield from soy fractions
10/03/2002WO2002077021A2 Streptococcus pneumoniae proteins and nucleic acids
10/03/2002WO2002077005A1 Pesticidal spinosyn derivatives
10/03/2002WO2002033057A3 Cytochrome p450 monooxygenases consisting of thermophilic bacteria
10/03/2002WO2002008440A3 Fermentation process for epothilones
10/03/2002US20020144308 Viral amplification of recombinant messenger RNA in transgenic plants
10/03/2002US20020143155 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects
10/03/2002US20020143150 Monoclonal antibody to the clonotypic structure of a T-cell receptor, a pharmaceutical composition and a diagnostic reagent comprising the same
10/03/2002US20020142947 By muta-synthesis using a mutated micro-organism to influence the biosynthesis of at least one of the precursors of group B streptogramines; mutant strain employed is preferably derived from the strain S. pristinaespiralis SP92
10/03/2002US20020142467 Method for culturing recombinant cells
10/03/2002US20020142436 Enzymatic protein for use in the treatment of tumors, nervous system, cardiovascular, psychological, pregnancy, bone, kidney, respiratory and alimentary canal disorders
10/03/2002US20020142425 Beta 1,3-galactosyltransferase and DNA encoding the same
10/03/2002US20020142424 Protein for use as a bioluminescent signaling tool
10/03/2002US20020142420 Cloned leptospira outer membrane protein
10/03/2002US20020142414 Nucleotide sequences coding polypeptide for use in the treatment of lung defects, septic shock or inflammation
10/03/2002US20020142409 Biocatalytic synthesis of quinic acid and conversion to hydroquinone
10/03/2002US20020142408 Production of cyclic terpenoids
10/03/2002US20020142406 Generating polyhydroxyalkanoates; obtain genetically cells which express enzymes associated with generation of polyhydroxyalanoates, incubate with 3-hydroxypropionate or 3-hydroxyvalerate, recover polyhydroxyalkonoates
10/03/2002US20020142405 Process for the preparation of L-amino acids by fermentation and nucleotide sequences coding for the accDA gene
10/03/2002US20020142400 Production of polyketides in bacteria and yeast
10/03/2002US20020142398 Chemokine expressed in fetal spleen, its production and uses
10/03/2002US20020142392 Human melanocyte stimulating hormone receptor polypeptide and DNA
10/03/2002US20020142388 Bacterial host strains
10/03/2002US20020142387 Methods for producing protein domains and analyzing three dimensional structures of proteins by using said domains
10/03/2002US20020142359 Monoclonal antibody to CEA, conjugates comprising said antibody, and their therapeutic use in an adept system
10/03/2002US20020142333 Heat resistant enzymatic polypeptide for use as a tool in nucleotide sequences analysis
10/03/2002US20020139495 Method for decomposing polyesters containing aromatic moieties, a denier reduction method of fiber, and microorganisms having activity of decomposing the polyester
10/03/2002CA2442089A1 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
10/03/2002CA2441267A1 Stereoselective reduction of substituted acetophenone
10/03/2002CA2439431A1 Streptococcus pneumoniae proteins and nucleic acids
10/02/2002EP1245678A2 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
10/02/2002EP1245677A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
10/02/2002EP1244802A2 Root-specific promoter
10/02/2002EP1244799A1 Methods and materials relating to gene expression
10/02/2002EP1244794A1 Mutant apre promoter
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244789A2 Genes identified as required for proliferation of e. coli
10/02/2002EP1244773A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
10/02/2002EP1244769A1 Production of peptides by fedbatch cultivation of a microorganism
10/02/2002EP1244463A1 Agent which is anti-adhesive in relation to the pathogenic flora of the skin
10/02/2002EP1244350A2 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal
10/02/2002EP1077068B9 Utilization of interferon alpha 5 in the treatment of viral hepatopathies
10/02/2002EP0923594B1 Bromotiacumicin compounds
10/02/2002EP0793503B1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
10/02/2002EP0792281B1 Process for purification of factor viii
10/02/2002EP0600930B1 Diagnosis and treatment of autoimmune diseases
10/02/2002DE10111682A1 Caloporosid-Derivate, Verfahren zu deren Herstellung und deren Verwendung Caloporoside derivatives, processes for their preparation and their use
10/02/2002CN1372599A Plant sterol acryltransferases
10/02/2002CN1372597A Method for producing L-amino acids by increasing cellular NADPH
10/02/2002CN1372592A Carrier for animal cell culture comprising organ tissue slice and animal cell culture method and transplantation method with the use of the carrier
10/02/2002CN1372569A Keratinocyte growth factor-2
10/02/2002CN1372568A Vaccin
10/02/2002CN1371991A Culture cell of Rhaphiolepis umbellata and method for culturing tissue using said cell
10/02/2002CN1371690A Vaccine composition for initiating anti-N-glycolyl ganglioside immunoreaction and application thereof
10/01/2002US6458944 Human BMP-4 promoter and method for exploring bone-related substance by using the same
10/01/2002US6458931 Immunoassay, immunotherapy; cancer; side effect reduction
10/01/2002US6458928 Microbial swollenin protein, DNA sequences encoding such swollenins and method of producing such swollenins
10/01/2002US6458586 Replication of defective vectors with mutations and deletions; gene therapy, vaccines, genetic engineering
10/01/2002US6458572 Phosphatidylglycerophosphate synthase from Staphylococcus aureus
10/01/2002US6458570 Process for the production of xylitol
10/01/2002US6458565 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers
10/01/2002US6458557 Culturing microorganism in presence of formate where cell is transformed with polynucleotide sequence which encodes a formate transporter associated protein; production of proteins in culture
10/01/2002US6458535 Detecting cleavage of nucleic acid cleavage structures using oligonucleotide probes and cleavage agents
10/01/2002US6458529 Assays for promoter operability in central nervous system cells
10/01/2002US6458527 Using synthetic or recombinant polypeptides as gag antigen; diagnosis of human immunodeficiency virus
10/01/2002US6458368 As vaccines for immunization
10/01/2002US6458366 Compounds and methods for diagnosis of tuberculosis
10/01/2002US6458360 Soluble complement regulatory molecules
10/01/2002US6458358 Compounds encoding the protective M-like protein of Streptococcus equi and assays therefor
10/01/2002US6458356 Antibody-induced apoptosis
10/01/2002US6458353 Anti-CCR2 antibodies and methods of use therefor
10/01/2002CA2224460C Process for producing gm2 specific antibodies
10/01/2002CA2168459C Fusion proteins containing the c-terminal of tetanus toxin linked to a heterologous protein
10/01/2002CA2145411C Viscous liquid xylitol compositions and process for preparing the same
10/01/2002CA2109602C Methods for producing members of specific binding pairs
10/01/2002CA2103546C Modified factor vii
10/01/2002CA2080482C Isolated promoter and terminator of elongation factor ef-1.alpha.
10/01/2002CA2075358C Multimers of the soluble forms of tnf receptors, their preparation and pharmaceutical compositions containing them
10/01/2002CA2073031C Anti-cd4 antibody homologs useful in prophylaxis and treatment of aids, arc and hiv infection
10/01/2002CA2011304C Expression vectors for the synthesis of proteins in the fission yeast schizosaccharomyces pombe
10/01/2002CA1341390C Human protein disulfide isomerase polypeptide and dna encoding the same
09/2002
09/28/2002CA2340455A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
09/26/2002WO2002074970A1 A process for the production of an inhibitor of human platelet aggregation and soybean lipoxygenase
09/26/2002WO2002074940A1 Method of extracting virus from cell culture
09/26/2002WO2002074934A1 Thermophilic microorganism bacillus coagulans strain sim-t dsm 14043 for the production of l(+)-lactate from fermentable sugars and their mixtures
09/26/2002WO2002074926A2 Myo-inositol oxygenases
09/26/2002WO2002074924A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
09/26/2002WO2002074800A1 Gene cluster for rabelomycin biosynthesis and its use to generate compounds for drug screening
09/26/2002WO2002074798A2 The genome of a bifidobacterium
09/26/2002WO2002074792A1 Fo-6979 substances and process for producing the same
09/26/2002WO2001090143A3 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions
09/26/2002WO2001011054A9 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STAPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB)
09/26/2002US20020138874 Elongase genes and uses thereof
09/26/2002US20020138872 Transgenic plants; enhanced defense mechanisms to combat plant diseases; disease resistant plants
09/26/2002US20020138454 Optimization of fermentation processes
09/26/2002US20020137921 Oligonucleotides having chiral phosphorus linkages
09/26/2002US20020137894 Megakaryocyte stimulating factors
09/26/2002US20020137788 Coniosetin and derivatives thereof, process for the preparation and the use thereof